Company Profile
Yantai Zhigong Biomedicine Technology Co., Ltd. was co-founded by returned overseas scholars and experts in the biopharmaceutical industry, serving as the Yantai Transformation Base for Baiyuan Gene. The company is pioneering uncharted territory in the cancer‑related field, addressing critical gaps in clinical diagnostics for bladder cancer. Building on its research in bladder cancer genomics and the development of early‑diagnosis gene chips, the company is advancing the R&D and industrial-scale production of products for bladder cancer early warning, prognosis, personalized medication guidance, infection monitoring, and biochemical diagnostics. Looking ahead, the company aims to become a “specialized, refined, distinctive, and innovative” enterprise in the field of molecular diagnostic instruments and associated reagents for reproductive‑tract tumors.
The Company’s Molecular Diagnostics Technology Innovation Center is a technology innovation hub established in Yantai by the Gansu Provincial Key Laboratory of Functional Genomics and Molecular Diagnostics and the Gansu Biochip Engineering Laboratory. Led by Professor Xu Jinzhang, a second‑level professor, and Professor Chen Yirong, a chief physician, the center leverages nucleic acid diagnostics, biochemical diagnostics, and immunoassay technologies to develop a range of rapid diagnostic methods across three key domains: medicine, environmental monitoring, and food safety. Its applications encompass the swift detection of infectious diseases, cancer, diabetes, and other conditions. The testing approaches incorporate compact, portable high‑throughput devices as well as flow‑based liquid‑phase chip technology, enabling the expansion of deployment scenarios to diverse settings, including specialized testing facilities, hospitals, community health centers, and customs and port checkpoints.
The center is equipped with laboratories including an IVD instrument R&D lab, a molecular biology lab, a physiochemical lab, a PCR lab, a separation and purification lab, a cell biology lab, a microbiology lab, and an immunology lab. It is furnished with specialized instruments and equipment, enabling it to meet the R&D needs for cutting-edge medical diagnostic instruments and associated diagnostic reagents. The center also provides services such as biomedical research support, technology development, technical consulting, technical exchange, and technology dissemination.
Corporate Culture
Zhigong Biology
Cherish life, prioritize health.
Corporate Mission
Focusing on precision prevention and treatment of cancer, Healthy China for Every Household
Corporate Vision
Sharing cutting-edge technologies and championing early cancer screening products.
Qualifications and Honors
Scientific and Technological Achievements
The company has obtained certifications from authoritative organizations, including ISO 13485 and ISO 9001 quality management system certifications, as well as the Intellectual Property Management System Certification.
As of the end of 2025, the company has been granted a total of 62 patents and registered 19 software copyrights.
The company has obtained 12 Class II medical device registration certificates and 167 Class I medical device filing certificates. Notably, the company’s three core instruments have received MDA certification in Malaysia, thereby securing international market access.
Participated in the development of five national standards and two industry standards, leveraging technical standards to guide the industry’s standardized development.
Registration Certificate
Patented invention
National Standard
Production Workshop
Yantai Zhigong Biomedicine Technology Co., Ltd.
Phone:+86-535-8209310
Email:zhigonggent@126.com
Address: Floor 9, Building 9, Shandong International Biotechnology Park, No. 39, Science Avenue, High-tech Zone, Yantai City, Shandong Province
WeChat Official Account